Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03641573 · ClinicalTrials.gov registry record · Phase 1
Phase 1 Study to Evaluate ASN002 Absorption, Metabolism, and Excretion of [14C] Following a Single Oral Dose in Healthy Male Subjects
A Phase 1 study, sponsored by Asana BioSciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT03641573 is a Phase 1 study that has completed, run by Asana BioSciences. The registered enrollment target is 8 participants.
The verdict
NCT03641573, a Phase 1 study, has completed, sponsored by Asana BioSciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of \[14C\] ASN002 Following a Single Oral Dose in Healthy Male Subjects
Interventions
- DRUG [14C] ASN002
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-10-11 |
| Est. Completion | 2018-10-21 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03641573
The ClinicalTrials.gov registry entry for NCT03641573 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Asana BioSciences, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [14C] ASN002 is the first listed.
NCT03641573 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03641573 about?
NCT03641573 is a clinical study titled "Phase 1 Study to Evaluate ASN002 Absorption, Metabolism, and Excretion of [14C] Following a Single Oral Dose in Healthy Male Subjects". Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of \[14C\] ASN002 Following a Single Oral Dose in Healthy Male Subjects
What is the current status of trial NCT03641573?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2018-10-11. Estimated completion is 2018-10-21.
What interventions are being tested in trial NCT03641573?
The interventions under investigation include: [14C] ASN002 (DRUG).
Who is sponsoring clinical trial NCT03641573?
This trial is sponsored by Asana BioSciences, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.